Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Capricor Therapeutics, Inc. (CAPR) had Receiveable Turnover of 2.43 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$25.18M |
|
$-22.29M |
|
-- |
|
$25.18M |
|
$49.26M |
|
$-24.08M |
|
$1.79M |
|
$-22.29M |
|
$-22.28M |
|
$-22.29M |
|
$-22.29M |
|
$-22.29M |
|
$-22.28M |
|
$-24.08M |
|
$-23.01M |
|
26.78M |
|
26.78M |
|
$-0.83 |
|
$-0.83 |
|
| Balance Sheet Financials | |
$50.86M |
|
$5.56M |
|
$7.88M |
|
$58.73M |
|
$31.27M |
|
-- |
|
$4.86M |
|
$36.13M |
|
$22.60M |
|
$22.60M |
|
$22.60M |
|
31.15M |
|
| Cash Flow Statement Financials | |
$-25.60M |
|
$5.11M |
|
$25.58M |
|
$9.60M |
|
$14.69M |
|
$5.09M |
|
$7.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.63 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-95.63% |
|
-95.63% |
|
-91.39% |
|
-88.52% |
|
-88.52% |
|
$-27.64M |
|
-- |
|
-- |
|
-- |
|
0.43 |
|
-- |
|
|
Receiveable Turnover |
2.43 |
150.36 |
|
-98.61% |
|
-98.61% |
|
-37.95% |
|
-98.61% |
|
$0.73 |
|
$-1.03 |
|
$-0.96 |
|